Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 9240
TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451264BDBM451264(US10709718, Compound 3)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451262BDBM451262(US10709718, Compound 1)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451398BDBM451398(US10709718, Compound 23)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451396BDBM451396(US10709718, Compound 21)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451394BDBM451394(US10709718, Compound 19)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451395BDBM451395(US10709718, Compound 20)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451392BDBM451392(US10709718, Compound 17)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451390BDBM451390(US10709718, Compound 13)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451391BDBM451391(US10709718, Compound 14)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451388BDBM451388(US10709718, Compound 11)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451382BDBM451382(US10709718, Compound 9)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451387BDBM451387(US10709718, Compound 10)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451381BDBM451381(US10709718, Compound 8)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451327BDBM451327(US10709718, Compound 5)
Affinity DataIC50: 10nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451263BDBM451263(US10709718, Compound 2)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451397BDBM451397(US10709718, Compound 22)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451393BDBM451393(US10709718, Compound 18)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451406BDBM451406(US10709718, Compound 34)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451404BDBM451404(US10709718, Compound 32)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451405BDBM451405(US10709718, Compound 33)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451389BDBM451389(US10709718, Compound 12)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451402BDBM451402(US10709718, Compound 30)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451403BDBM451403(US10709718, Compound 31)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451400BDBM451400(US10709718, Compound 25)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451401BDBM451401(US10709718, Compound 26)
Affinity DataIC50: 55nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451370BDBM451370(US10709718, Compound 7)
Affinity DataIC50: 550nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451399BDBM451399(US10709718, Compound 24)
Affinity DataIC50: 550nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Metabasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 451368BDBM451368(US10709718, Compound 6)
Affinity DataIC50: 550nMAssay Description:The inhibition of DGAT-1 activity can be assessed in intestinal microsome preparations by monitoring the incorporation of radiolabeled fatty acyl-CoA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
US Patent